A systematic search of PubMed, Scopus, Web of Science, and the Cochrane Library, along with manual searches, identified studies assessing GLP-1 agonists in BED patients up to November 8, 2024. The gene discussed is GLP1R; the disease is X-linked cone dysfunction syndrome with myopia.